By Dr Christopher Muir

Journal articles

Sleiman S; Bacha F; Di Pierro I; Idan A; Savkovic S; Muir CA; Zhang T; Jayadev V; Conway AJ; Handelsman DJ, 2024, 'Natural history of autologous sperm cryostorage.', Hum Reprod, http://dx.doi.org/10.1093/humrep/deae217

Muir CA; Guttman-Jones M; Man EJ, 2024, 'Effects of gender affirming hormone treatment in transgender individuals – a retrospective cohort study', Endocrine, 85, pp. 370 - 379, http://dx.doi.org/10.1007/s12020-024-03736-0

McMartin MC; Savkovic S; Romano A; Lim S; Muir CA; Jayadev V; Conway AJ; Seccombe L; Handelsman DJ, 2024, 'Testosterone and Erythrocyte Lifespan.', J Clin Endocrinol Metab, http://dx.doi.org/10.1210/clinem/dgae434

Muir CA; Kuang W; Muthiah K; Greenfield JR; Raven LM, 2024, 'Association of early post-transplant hyperglycaemia and diabetes mellitus on outcomes following heart transplantation', Diabetic Medicine, http://dx.doi.org/10.1111/dme.15441

Petersenn S; Fleseriu M; Casanueva FF; Giustina A; Biermasz N; Biller BMK; Bronstein M; Chanson P; Fukuoka H; Gadelha M; Greenman Y; Gurnell M; Ho KKY; Honegger J; Ioachimescu AG; Kaiser UB; Karavitaki N; Katznelson L; Lodish M; Maiter D; Marcus HJ; McCormack A; Molitch M; Muir CA; Neggers S; Pereira AM; Pivonello R; Post K; Raverot G; Salvatori R; Samson SL; Shimon I; Spencer-Segal J; Vila G; Wass J; Melmed S, 2024, 'Author Correction: Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement (Nature Reviews Endocrinology, (2023), 19, 12, (722-740), 10.1038/s41574-023-00886-5)', Nature Reviews Endocrinology, 20, pp. 62, http://dx.doi.org/10.1038/s41574-023-00916-2

Kuang W; Raven LM; Muir CA, 2024, 'Early post-transplant hyperglycemia and post-transplant diabetes mellitus following heart transplantation', Expert Review of Endocrinology and Metabolism, 19, pp. 129 - 140, http://dx.doi.org/10.1080/17446651.2024.2307011

Muir CA; Zhang T; Jayadev V; Conway AJ; Handelsman DJ, 2024, 'Efficacy of Gonadotropin Treatment for Induction of Spermatogenesis in Men With Pathologic Gonadotropin Deficiency: A Meta-Analysis', Clinical Endocrinology, http://dx.doi.org/10.1111/cen.15151

Raven LM; Muir CA; Deveza RC; Kessler Iglesias C; Bart NK; Muthiah K; Kotlyar E; Hayward CS; Macdonald PS; Jabbour A; Greenfield JR, 2024, 'Effect of sodium glucose cotransporter 2 inhibition immediately prior to heart transplantation', JHLT Open, 5, pp. 100088 - 100088, http://dx.doi.org/10.1016/j.jhlto.2024.100088

Raven LM; Muir CA; Kessler Iglesias C; Bart NK; Muthiah K; Kotlyar E; Hayward CS; Macdonald PS; Jabbour A; Greenfield JR, 2024, 'Safety of Sodium Glucose Co-Transporter 2 Inhibitor Exposure Prior to Heart Transplantation', The Journal of Heart and Lung Transplantation, 43, pp. S148 - S149, http://dx.doi.org/10.1016/j.healun.2024.02.302

Raven LM; Goodall L; Center JR; Muir CA, 2024, 'Teriparatide as Treatment for Severe Osteoporosis in Lung Transplant Recipients.', JCEM Case Rep, 2, pp. luae026, http://dx.doi.org/10.1210/jcemcr/luae026

Petersenn S; Fleseriu M; Casanueva FF; Giustina A; Biermasz N; Biller BMK; Bronstein M; Chanson P; Fukuoka H; Gadelha M; Greenman Y; Gurnell M; Ho KKY; Honegger J; Ioachimescu AG; Kaiser UB; Karavitaki N; Katznelson L; Lodish M; Maiter D; Marcus HJ; McCormack A; Molitch M; Muir CA; Neggers S; Pereira AM; Pivonello R; Post K; Raverot G; Salvatori R; Samson SL; Shimon I; Spencer-Segal J; Vila G; Wass J; Melmed S, 2023, 'Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement', Nature Reviews Endocrinology, 19, pp. 722 - 740, http://dx.doi.org/10.1038/s41574-023-00886-5

Raven LM; Muir CA; Kessler Iglesias C; Kotlyar E; Muthiah K; Bart NK; Macdonald PS; Hayward CS; Jabbour A; Greenfield JR, 2023, 'THU298 Effect Of SGLT2 Inhibition On Metabolic, Cardiac And Renal Outcomes In Heart Transplant Recipients (EMPA-HTx study): Protocol And Study Design', Journal of the Endocrine Society, 7, http://dx.doi.org/10.1210/jendso/bvad114.733

Raven LM; Muir CA; Greenfield JR, 2023, 'Sodium glucose cotransporter 2 inhibitor-induced ketoacidosis is unlikely in patients without diabetes', Medical Journal of Australia, 219, pp. 293 - 294, http://dx.doi.org/10.5694/mja2.52067

Raven LM; Muir CA; Pouliopoulos J; Hayward CS; Macdonald PS; Greenfield JR; Jabbour A, 2023, 'Metabolic Sequelae of Everolimus Treatment After Cardiac Transplant: A Hypothesis-Generating Study', Heart Lung and Circulation, 32, pp. 1076 - 1079, http://dx.doi.org/10.1016/j.hlc.2023.05.014

RAVEN LM; MUIR CA; POULIOPOULOS JIM; MACDONALD PS; JABBOUR A; GREENFIELD J, 2023, '1438-P: Diabetes after Cardiac Transplant with Low-Dose Everolimus and Tacrolimus', Diabetes, 72, http://dx.doi.org/10.2337/db23-1438-p

Raven LM; Muir CA; Macdonald PS; Hayward CS; Jabbour A; Greenfield JR, 2023, 'Diabetes medication following heart transplantation: a focus on novel cardioprotective therapies—a joint review from endocrinologists and cardiologists', Acta Diabetologica, 60, pp. 471 - 480, http://dx.doi.org/10.1007/s00592-022-02018-3

Raven LM; Muir CA; Kessler Iglesias C; Bart NK; Muthiah K; Kotlyar E; Macdonald P; Hayward CS; Jabbour A; Greenfield JR, 2023, 'Sodium glucose co-transporter 2 inhibition with empagliflozin on metabolic, cardiac and renal outcomes in recent cardiac transplant recipients (EMPA-HTx): Protocol for a randomised controlled trial', BMJ Open, 13, http://dx.doi.org/10.1136/bmjopen-2022-069641

Raven LM; Greenfield JR; Muir CA, 2023, 'Glucagon-like Peptide-1 Receptor Agonist Treatment With Semaglutide in Type 1 Diabetes.', JCEM Case Rep, 1, pp. luac017, http://dx.doi.org/10.1210/jcemcr/luac017

Muir CA; Tsang VHM; Menzies AM; Clifton-Bligh RJ, 2022, 'Immune Related Adverse Events of the Thyroid – A Narrative Review', Frontiers in Endocrinology, 13, http://dx.doi.org/10.3389/fendo.2022.886930

Muir CA; Wood CCG; Clifton-Bligh RJ; Long GV; Scolyer RA; Carlino MS; Menzies AM; Tsang VHM, 2022, 'Association of Antithyroid Antibodies in Checkpoint Inhibitor-Associated Thyroid Immune-Related Adverse Events', Journal of Clinical Endocrinology and Metabolism, 107, pp. E1843 - E1849, http://dx.doi.org/10.1210/clinem/dgac059

Raven LM; Muir CA, 2021, 'Something to chew on: an unusual case of hyponatraemia secondary to chewing gum ingestion', Internal Medicine Journal, 51, pp. 1748 - 1749, http://dx.doi.org/10.1111/imj.15521

Muir CA; Clifton-Bligh RJ; Long GV; Scolyer RA; Lo SN; Carlino MS; Tsang VHM; Menzies AM, 2021, 'Thyroid Immune-related Adverse Events following Immune Checkpoint Inhibitor Treatment', Journal of Clinical Endocrinology and Metabolism, 106, pp. E3704 - E3713, http://dx.doi.org/10.1210/clinem/dgab263

Muir CA; Menzies AM; Clifton-Bligh RJ; Long GV; Scolyer RA; Tsang V, 2021, 'Phenotypic Differences in Thyroid Immune Related Adverse Events Following Treatment With Immune Checkpoint Inhibitors', Journal of the Endocrine Society, 5, pp. A876 - A877, http://dx.doi.org/10.1210/jendso/bvab048.1790

Raven LM; Guttman-Jones M; Muir CA, 2021, 'Hyperprolactinemia and association with prolactinoma in transwomen receiving gender affirming hormone treatment', Endocrine, 72, pp. 524 - 528, http://dx.doi.org/10.1007/s12020-020-02563-3

Muir CA; Menzies AM; Clifton-Bligh R; Tsang VHM, 2020, 'Thyroid Toxicity following Immune Checkpoint Inhibitor Treatment in Advanced Cancer', Thyroid, 30, pp. 1458 - 1469, http://dx.doi.org/10.1089/thy.2020.0032

Muir CA; Jones GRD; Greenfield JR; Weissberger A; Samaras K, 2020, 'THYROID PEROXIDASE ANTIBODY POSITIVITY IS ASSOCIATED with RELAPSE-FREE SURVIVAL following ANTITHYROID DRUG TREATMENT for GRAVES DISEASE', Endocrine Practice, 26, pp. 1026 - 1030, http://dx.doi.org/10.4158/EP-2020-0035

Muir CA; Munsif A; Blaker K; Feng Y; D'Souza M; Tewari S, 2020, 'Antenatal Thyroid Function Does Not Increase Risk of Gestational Diabetes Mellitus in a Multi-Ethnic Pregnancy Cohort', International Journal of Thyroidology, 13, pp. 13 - 18, http://dx.doi.org/10.11106/ijt.2020.13.1.13

Muir CA; Greenfield JR; Weissberger A; Jones GRD; Samaras K, 2020, 'SAT-LB75 Thyroid Peroxidase Antibody Positivity Predicts Relapse Free Survival Following Anti-Thyroid Drug Treatment for Graves Disease', Journal of the Endocrine Society, 4, http://dx.doi.org/10.1210/jendso/bvaa046.2016

Kattge J; Bönisch G; Díaz S; Lavorel S; Prentice IC; Leadley P; Tautenhahn S; Werner GDA; Aakala T; Abedi M; Acosta ATR; Adamidis GC; Adamson K; Aiba M; Albert CH; Alcántara JM; Alcázar C C; Aleixo I; Ali H; Amiaud B; Ammer C; Amoroso MM; Anand M; Anderson C; Anten N; Antos J; Apgaua DMG; Ashman TL; Asmara DH; Asner GP; Aspinwall M; Atkin O; Aubin I; Baastrup-Spohr L; Bahalkeh K; Bahn M; Baker T; Baker WJ; Bakker JP; Baldocchi D; Baltzer J; Banerjee A; Baranger A; Barlow J; Barneche DR; Baruch Z; Bastianelli D; Battles J; Bauerle W; Bauters M; Bazzato E; Beckmann M; Beeckman H; Beierkuhnlein C; Bekker R; Belfry G; Belluau M; Beloiu M; Benavides R; Benomar L; Berdugo-Lattke ML; Berenguer E; Bergamin R; Bergmann J; Bergmann Carlucci M; Berner L; Bernhardt-Römermann M; Bigler C; Bjorkman AD; Blackman C; Blanco C; Blonder B; Blumenthal D; Bocanegra-González KT; Boeckx P; Bohlman S; Böhning-Gaese K; Boisvert-Marsh L; Bond W; Bond-Lamberty B; Boom A; Boonman CCF; Bordin K; Boughton EH; Boukili V; Bowman DMJS; Bravo S; Brendel MR; Broadley MR; Brown KA; Bruelheide H; Brumnich F; Bruun HH; Bruy D; Buchanan SW; Bucher SF; Buchmann N; Buitenwerf R; Bunker DE; Bürger J; Moles A; Cornwell W; Falster D; Muir C; Martin A; Wenk E, 2020, 'TRY plant trait database – enhanced coverage and open access', Global Change Biology, 26, pp. 119 - 188, http://dx.doi.org/10.1111/gcb.14904

Lo P; Kearney K; Muir CA; Song N; Eisman JA; Macdonald PS, 2020, 'SEVERE HYPERTRIGLYCERIDEMIA ASSOCIATED WITH EVEROLIMUS TREATMENT AFTER HEART TRANSPLANTATION.', AACE Clin Case Rep, 6, pp. e269 - e272, http://dx.doi.org/10.4158/ACCR-2020-0191

Cehic MG; Muir CA; Greenfield JR; Hayward C; Jabbour A; Keogh A; Kotlyar E; Muthiah K; Macdonald PS, 2019, 'Efficacy and Safety of Empagliflozin in the Management of Diabetes Mellitus in Heart Transplant Recipients', Transplantation Direct, 5, pp. e450, http://dx.doi.org/10.1097/TXD.0000000000000885

Muir C; Dwight T; Center J; Greenfield J; Clifton-Bligh R; Lee P, 2019, 'MON-378 Somatic HIF2α Mutation and Pheochromocytoma in a Patient with Cyanotic Congenital Heart Disease', Journal of the Endocrine Society, 3, http://dx.doi.org/10.1210/js.2019-mon-378

Muir C; Szajer J; Mansberg R; Russo R; Banh J; Boyle R; Crawford BA, 2018, 'Low bone mineral density in a man with recurrent minimal trauma fractures: a cauTIOnary tale of unrecognised hypophosphataemia', Internal Medicine Journal, 48, pp. 1003 - 1004, http://dx.doi.org/10.1111/imj.13980

Muir CA; Greenfield JR; MacDonald PS, 2017, 'Empagliflozin in the management of diabetes mellitus after cardiac transplantation', Journal of Heart and Lung Transplantation, 36, pp. 914 - 916, http://dx.doi.org/10.1016/j.healun.2017.05.005

Muir C; Dodds A; Samaras K, 2017, 'Mid-life extra-haematopoetic manifestations of Diamond-Blackfan anaemia', ENDOCRINOLOGY DIABETES AND METABOLISM CASE REPORTS, http://dx.doi.org/10.1530/EDM-16-0141

Lau SL; Muir C; Assur Y; Beach R; Tran B; Bartrop R; Mclean M; Caetano D, 2016, 'Predicting weight gain in patients treated with clozapine: The role of sex, body mass index, and smoking', Journal of Clinical Psychopharmacology, 36, pp. 120 - 124, http://dx.doi.org/10.1097/JCP.0000000000000476

Muir CA; Kotwal SS; Hawley CM; Polkinghorne K; Gallagher MP; Snelling P; Jardine MJ, 2014, 'Buttonhole cannulation and clinical outcomes in a home hemodialysis cohort and systematic review', Clinical Journal of the American Society of Nephrology, 9, pp. 110 - 119, http://dx.doi.org/10.2215/CJN.03930413

Adamec R; Muir C; Grimes M; Pearcey K, 2007, 'Involvement of noradrenergic and corticoid receptors in the consolidation of the lasting anxiogenic effects of predator stress', Behavioural Brain Research, 179, pp. 192 - 207, http://dx.doi.org/10.1016/j.bbr.2007.02.001

Back to profile page